Investigations on the Respiratory Function in COVID-19 Patients: A Prospective Cohort StudyResearch Article Published on 2021-12-262022-10-27 Journal: BioMed Research International [Category] COVID-19, [키워드] activity aerobic Anxiety conducted Coronavirus disease 2019 COVID-19 COVID-19 patients Critical case daily living Depression dysfunction Dyspnea eligible patient Fever Follow-up function global public health hospital investigation men Mental Mild moderate outcome participant Patient patients with COVID-19 physical proportion Prospective psychological disorder Psychological intervention Quality of life rehabilitation respiratory Respiratory function Result Symptoms the patient was collected women [DOI] 10.1155/2021/9928276 PMC 바로가기 [Article Type] Research Article
Investigations on the Respiratory Function in COVID-19 Patients: A Prospective Cohort StudyResearch Article Published on 2021-12-262022-10-27 Journal: BioMed Research International [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] activity aerobic Anxiety conducted Coronavirus disease 2019 COVID-19 COVID-19 patients Critical case daily living Depression dysfunction Dyspnea eligible patient Fever Follow-up function global public health hospital investigation men Mental Mild moderate outcome participant Patient patients with COVID-19 physical proportion Prospective psychological disorder Psychological intervention Quality of life rehabilitation respiratory Respiratory function Result Symptoms the patient was collected women [DOI] 10.1155/2021/9928276 PMC 바로가기 [Article Type] Research Article
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study미국에서 Covid-19 회복기 혈장의 접근 및 안전성 확장 접근 프로그램 : 전국 레지스트리 연구Clinical Trial Published on 2021-12-202022-09-10 Journal: PLoS Medicine [Category] SARS, 신약개발, 임상, 진단, [키워드] 30-day mortality rate 95% CI access acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Administered affected age Analysis approval blood collection causative agent central institutional review board changes in characteristics of patient Clinical characteristics clinical trials convalescent plasma coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 convalescent plasma demographic demographic and clinical characteristics demographic group demographic groups early stage early stages effective effort eligible patient Eligible patients Emerging infectious disease enrolled Enrollment Evidence example Expanded access Expanded Access Program Factor framework Hispanic ethnicity hospital Hospitalized hospitalized patient hospitalized patients incidence include Inclusion increases in Infection infection rate Infectious disease initiated institutional review board investigated investigator less life-threatening Local majority male Mayo Clinic Metrics mortality rate National obesity observational study Older overweight Patient plasma populations potential therapeutic agents Pragmatic progression provided public health public health emergency Racial randomized clinical trial Region regions registry data regulatory pathway regulatory pathways required researcher respiratory resulting risk Safe safety profile SARS-CoV-2 Serious Adverse Event Serious Adverse Events severe acute respiratory syndrome Coronavirus Spread Stage Study design Temporal the United State The United States therapy transfused transfusion Treatment treatment effects Trial registration United State United States website while widespread with COVID-19 [DOI] 10.1371/journal.pmed.1003872 PMC 바로가기 [Article Type] Clinical Trial
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studyResearch article Published on 2021-12-012022-10-05 Journal: The Lancet Rheumatology [Category] 유전자 메커니즘, [키워드] age Alliance Analysis antibody college Comorbidity conditions COVID-19 COVID-19 in patient COVID-19 severity cytoplasmic death defined demographic factor diagnosed with COVID-19 died disease Disease activity Diseases eligible patient European Factor female finding funding giant cell arteritis glucocorticoid Glucocorticoids had more high risk High-dose higher odd hospitalisation hospitalised male medication men moderate number of comorbidities obesity Odds ratio Older ordinal logistic regression organ damage outcome Patient patients Prednisolone receive supplemental oxygen reported retrospective cohort study Risk factors severe COVID-19 severe disease Sex smoking status stratified Subtypes supplemental oxygen syndrome Treatment Vasculitis Ventilation were used with COVID-19 women [DOI] 10.1016/S2665-9913(21)00316-7 [Article Type] Research article
Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trialCOVID-19 환자에서 소포스부비르와 다클라타스비르 또는 라비다스비르의 효능 및 안전성: 무작위 대조 시험Clinical Trial Published on 2021-12-012022-09-11 Journal: Journal of medical virology [Category] 신약개발, 임상, 치료제, [키워드] added addition Admission Antiviral antiviral drugs Antiviral treatment approved ARMS clinical impact coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 infections daclatasvir Day DCV Deterioration distress effective therapy Efficacy Efficacy and safety eligible patient endpoints evaluate Evidence evidence of Fever headache ICU ICU admission identify improvement incidence infections intensive care intensive care unit mechanical ventilation moderate moderate to severe Mortality negativity no evidence of Open-label open-label trial oxygen oxygen saturation Patient patients with moderate positive Randomized Randomized controlled trial ravidasvir RDV repurposing repurposing antiviral drugs respiratory distress Severe COVID-19 Infection severe COVID-19 infections significantly significantly lower sofosbuvir sofosbuvir plus daclatasvir standard care Standard of care Support Symptom Treatment Trial [DOI] 10.1002/jmv.27264 PMC 바로가기 [Article Type] Clinical Trial
Capacity and use of diagnostics and treatment for patients with severe acute respiratory infections in the pre-COVID-19 era in district and provincial hospitals in Viet NamObservational Study Published on 2021-11-302022-10-04 Journal: Western Pacific Surveillance and Response Journal [Category] MERS, SARS, 임상, [키워드] 24 hour Acute respiratory infection Admission Antibiotics barrier Capacity Care CCU collected collected data conducted Critical care Culture demographics diagnostic tests diagnostics eligible patient Factor FIVE hospital hospital equipment hospitals include Inflammatory marker Influenza information interquartile Intervention male management mechanical ventilation median age medication Medicine microbial Mortality objective oseltamivir outcome Patient patients presenting Respiratory Support Result Septic shock significant difference the patient Treatment [DOI] 10.5365/wpsar.2021.12.4.835 PMC 바로가기 [Article Type] Observational Study
Pre-hospital, in-hospital and post-hospital factors associated with sleep quality among COVID-19 survivors 6 months after hospital discharge: cross-sectional survey in five cities in ChinaRehabilitation and Social Published on 2021-11-112022-10-27 Journal: BJPsych Open [Category] COVID-19, [키워드] 95% CI adjusted adult COVID-19 patient anxiety symptom Characteristics China Chinese COVID-19 COVID-19 patient COVID-19 survivors cross-sectional survey death depressive symptom discharged disorder eligible patient Factor FIVE hospital hospital discharge Hospital stay IMPROVE In-hospital in-hospital factors Intervention investigated Multiple linear regression Participants post-hospital factors Post-traumatic stress disorder pre-hospital factors provided Quality reported Result scale Sleep sleep quality Support survivor understanding verbal [DOI] 10.1192/bjo.2021.1008 PMC 바로가기 [Article Type] Rehabilitation and Social
513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 InfectionPoster Abstracts Published on 2021-11-042022-10-29 Journal: Open Forum Infectious Diseases [Category] COVID-19, [키워드] acute respiratory syndrome adverse event Algorithm antimicrobial approach approval approved ASP benefit Cohort collected complications coronavirus coronavirus disease COVID-19 death decrease demographics Dual therapy effort eligibility eligible patient Emergency use authorization EUA hospital Hospitalization Infection male monoclonal antibody monotherapy Nurse occurred online tool outcome pandemic Patient patients required hospitalization physician Physicians Program provided receive receiving Regulatory reported Result SARS-CoV-2 SARS-COV-2 infection screened Support therapy treated patients white [DOI] 10.1093/ofid/ofab466.712 PMC 바로가기 [Article Type] Poster Abstracts
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients: An observational studyObservational Study Published on 2021-11-012022-10-05 Journal: International immunopharmacology [Category] SARS, 임상, [키워드] 95% CI acute respiratory distress antiviral response association Biomarker cHIS. Clinical outcome Cohort Complication Concentration conducted control group correlated COVID-19 COVID-19 patient CRS cytokine releasing syndrome deficiency diagnosed with COVID-19 early stage eligible patient Hospital stay hospitalized COVID-19 hospitalized COVID-19 patient hospitalized COVID-19 patients Hyperinflammatory syndrome Infection Inflammation interquartile range IQR majority median median age morbidity Mortality Non-COVID-19 outcome outcomes Patient PCR-confirmed plasma zinc concentration Prevalence Prognostic marker retrospective risk robust SARS-CoV-2 severe SARS-CoV-2 significantly single-center Support syndrome tested the disease university hospital Zinc [DOI] 10.1016/j.intimp.2021.108163 PMC 바로가기 [Article Type] Observational Study
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort studyClinical Trial Published on 2021-11-012022-10-04 Journal: The Lancet. Oncology [Category] SARS, 임상, [키워드] 95% CI adjusted hazard ratio association calculated Cancer Care cohort study country COVID-19 COVID-19 pandemic curative defined Diagnosis Effect Elective surgery eligible patient enrolled European Follow-up foundation Gastrointestinal global health Government Great Britain groups hospital identify include index International interval IQR Ireland LIGHT lockdown lockdowns median Medtronic moderate National no difference Outbreaks outcome Oxford pathway Patient planned surgery Primary outcome proportion PROTECT public health emergency receive reductions in Region Registered Regression model remained Resilience Sarcoma SARS-CoV-2 selected Sensitivity analyses Seven Society solid cancer surgery surgical survival therapy to define undergo unit upper Urology were used [DOI] 10.1016/S1470-2045(21)00493-9 PMC 바로가기 [Article Type] Clinical Trial